Imaging Dopaminergic Dysfunction as a Surrogate Marker of Neuropathology in a Small-Animal Model of HIV

The dopaminergic system is especially vulnerable to the effects of human immunodeficiency virus (HIV) infection, rendering dopaminergic deficits early surrogate markers of HIV-associated neuropathology. We quantified dopamine D 2/3 receptors in young HIV-1 transgenic (Tg) ( n = 6) and age-matched co...

Full description

Bibliographic Details
Main Authors: Dianne E. Lee, William C. Reid, Wael G. Ibrahim, Kristin L. Peterson, Margaret R. Lentz, Dragan Maric, Peter L. Choyke, Elaine M. Jagoda, Dima A. Hammoud
Format: Article
Language:English
Published: SAGE Publications 2014-11-01
Series:Molecular Imaging
Online Access:https://doi.org/10.2310/7290.2014.00031
_version_ 1797283810619949056
author Dianne E. Lee
William C. Reid
Wael G. Ibrahim
Kristin L. Peterson
Margaret R. Lentz
Dragan Maric
Peter L. Choyke
Elaine M. Jagoda
Dima A. Hammoud
author_facet Dianne E. Lee
William C. Reid
Wael G. Ibrahim
Kristin L. Peterson
Margaret R. Lentz
Dragan Maric
Peter L. Choyke
Elaine M. Jagoda
Dima A. Hammoud
author_sort Dianne E. Lee
collection DOAJ
description The dopaminergic system is especially vulnerable to the effects of human immunodeficiency virus (HIV) infection, rendering dopaminergic deficits early surrogate markers of HIV-associated neuropathology. We quantified dopamine D 2/3 receptors in young HIV-1 transgenic (Tg) ( n = 6) and age-matched control rats ( n = 7) and adult Tg ( n = 5) and age-matched control rats ( n = 5) using [ 18 F]fallypride positron emission tomography (PET). Regional uptake was quantified as binding potential ( BP ND ) using the two-tissue reference model with the cerebellum as the reference. Time-activity curves were generated for the ventral striatum, dorsal striatum, thalamus, and cerebellum. Whereas BP ND values were significantly lower in the ventral striatum ( p < .001) and dorsal striatum ( p = .001) in the adult Tg rats compared to controls rats, they were significantly lower only in the dorsal striatum ( p < .05) in the young rats. Tg rats had smaller striatal volumes on magnetic resonance imaging. We also found lower expression levels of tyrosine hydroxylase on immunohistochemistry in the Tg animals. Our findings suggest that progressive striatal D 2/3 receptor deficits occur in Tg rats as they age and can be detected using small-animal PET imaging. The effectiveness of various approaches in preventing or halting this dopaminergic loss in the Tg rat can thus be measured preclinically using [ 18 F]fallypride PET as a molecular imaging biomarker of HIV-associated neuropathology.
first_indexed 2024-03-07T17:37:13Z
format Article
id doaj.art-9cf9a32a11c549708dc554faef5e8f55
institution Directory Open Access Journal
issn 1536-0121
language English
last_indexed 2024-03-07T17:37:13Z
publishDate 2014-11-01
publisher SAGE Publications
record_format Article
series Molecular Imaging
spelling doaj.art-9cf9a32a11c549708dc554faef5e8f552024-03-02T16:42:57ZengSAGE PublicationsMolecular Imaging1536-01212014-11-011310.2310/7290.2014.0003110.2310_7290.2014.00031Imaging Dopaminergic Dysfunction as a Surrogate Marker of Neuropathology in a Small-Animal Model of HIVDianne E. LeeWilliam C. ReidWael G. IbrahimKristin L. PetersonMargaret R. LentzDragan MaricPeter L. ChoykeElaine M. JagodaDima A. HammoudThe dopaminergic system is especially vulnerable to the effects of human immunodeficiency virus (HIV) infection, rendering dopaminergic deficits early surrogate markers of HIV-associated neuropathology. We quantified dopamine D 2/3 receptors in young HIV-1 transgenic (Tg) ( n = 6) and age-matched control rats ( n = 7) and adult Tg ( n = 5) and age-matched control rats ( n = 5) using [ 18 F]fallypride positron emission tomography (PET). Regional uptake was quantified as binding potential ( BP ND ) using the two-tissue reference model with the cerebellum as the reference. Time-activity curves were generated for the ventral striatum, dorsal striatum, thalamus, and cerebellum. Whereas BP ND values were significantly lower in the ventral striatum ( p < .001) and dorsal striatum ( p = .001) in the adult Tg rats compared to controls rats, they were significantly lower only in the dorsal striatum ( p < .05) in the young rats. Tg rats had smaller striatal volumes on magnetic resonance imaging. We also found lower expression levels of tyrosine hydroxylase on immunohistochemistry in the Tg animals. Our findings suggest that progressive striatal D 2/3 receptor deficits occur in Tg rats as they age and can be detected using small-animal PET imaging. The effectiveness of various approaches in preventing or halting this dopaminergic loss in the Tg rat can thus be measured preclinically using [ 18 F]fallypride PET as a molecular imaging biomarker of HIV-associated neuropathology.https://doi.org/10.2310/7290.2014.00031
spellingShingle Dianne E. Lee
William C. Reid
Wael G. Ibrahim
Kristin L. Peterson
Margaret R. Lentz
Dragan Maric
Peter L. Choyke
Elaine M. Jagoda
Dima A. Hammoud
Imaging Dopaminergic Dysfunction as a Surrogate Marker of Neuropathology in a Small-Animal Model of HIV
Molecular Imaging
title Imaging Dopaminergic Dysfunction as a Surrogate Marker of Neuropathology in a Small-Animal Model of HIV
title_full Imaging Dopaminergic Dysfunction as a Surrogate Marker of Neuropathology in a Small-Animal Model of HIV
title_fullStr Imaging Dopaminergic Dysfunction as a Surrogate Marker of Neuropathology in a Small-Animal Model of HIV
title_full_unstemmed Imaging Dopaminergic Dysfunction as a Surrogate Marker of Neuropathology in a Small-Animal Model of HIV
title_short Imaging Dopaminergic Dysfunction as a Surrogate Marker of Neuropathology in a Small-Animal Model of HIV
title_sort imaging dopaminergic dysfunction as a surrogate marker of neuropathology in a small animal model of hiv
url https://doi.org/10.2310/7290.2014.00031
work_keys_str_mv AT dianneelee imagingdopaminergicdysfunctionasasurrogatemarkerofneuropathologyinasmallanimalmodelofhiv
AT williamcreid imagingdopaminergicdysfunctionasasurrogatemarkerofneuropathologyinasmallanimalmodelofhiv
AT waelgibrahim imagingdopaminergicdysfunctionasasurrogatemarkerofneuropathologyinasmallanimalmodelofhiv
AT kristinlpeterson imagingdopaminergicdysfunctionasasurrogatemarkerofneuropathologyinasmallanimalmodelofhiv
AT margaretrlentz imagingdopaminergicdysfunctionasasurrogatemarkerofneuropathologyinasmallanimalmodelofhiv
AT draganmaric imagingdopaminergicdysfunctionasasurrogatemarkerofneuropathologyinasmallanimalmodelofhiv
AT peterlchoyke imagingdopaminergicdysfunctionasasurrogatemarkerofneuropathologyinasmallanimalmodelofhiv
AT elainemjagoda imagingdopaminergicdysfunctionasasurrogatemarkerofneuropathologyinasmallanimalmodelofhiv
AT dimaahammoud imagingdopaminergicdysfunctionasasurrogatemarkerofneuropathologyinasmallanimalmodelofhiv